Skip to main content
VCbacked
Log inGet Started

Everest Medicines

New York, United States

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

$6.8M raised
May 2026
Post-IPO Secondary
BiotechnologyHealth CarePharmaceutical

Top Investors

RA Capital ManagementHillhouse InvestmentJanus Henderson InvestorsDecheng CapitalPavilion Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Everest Medicines

How much funding has Everest Medicines raised?
Everest Medicines has raised $6.8M in total funding. The most recent round was Post-IPO Secondary. The last funding was announced in May 2026.
Who are Everest Medicines's investors?
Everest Medicines's investors include RA Capital Management, Hillhouse Investment, Janus Henderson Investors, Decheng Capital, Pavilion Capital.
Where is Everest Medicines headquartered?
Everest Medicines is headquartered in New York, United States.
What does Everest Medicines do?
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
What stage is Everest Medicines at?
Everest Medicines is at the Post-IPO Secondary stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Everest Medicines — Funding & Investors." VCBacked, May 14, 2026, https://www.vcbacked.co/company/everest-medicines. Accessed July 3, 2026.
APA
VCBacked. (2026). Everest Medicines — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/everest-medicines
Wikipedia (cite web)
{{cite web |title=Everest Medicines — Funding & Investors |url=https://www.vcbacked.co/company/everest-medicines |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K